Characteristics of study subjects with different CD4+ cell numbers
. | > 300 CD4+ cells/μL . | < 300 CD4+cells/μL . | P . |
---|---|---|---|
No. of subjects | 10 | 10 | |
Age, y | |||
Median | 46 | 41 | |
Range | (34-59) | (31-55) | |
CD4+cell number/μL | |||
Median | 629 ± 164 | 220 ± 58 | .001 |
Range | (481-1 011) | (136-298) | |
CD8+ cell number/μL | |||
Median | 1 605 ± 1 074 | 677 ± 331 | .01 |
Range | (581-3 623) | (204-1 371) | |
Viral load (RNA/mL) | |||
Median | 4 173 ± 8 988 | 26 314 ± 37 189 | .03 |
Range | (50-29 000) | (50-117 963) |
. | > 300 CD4+ cells/μL . | < 300 CD4+cells/μL . | P . |
---|---|---|---|
No. of subjects | 10 | 10 | |
Age, y | |||
Median | 46 | 41 | |
Range | (34-59) | (31-55) | |
CD4+cell number/μL | |||
Median | 629 ± 164 | 220 ± 58 | .001 |
Range | (481-1 011) | (136-298) | |
CD8+ cell number/μL | |||
Median | 1 605 ± 1 074 | 677 ± 331 | .01 |
Range | (581-3 623) | (204-1 371) | |
Viral load (RNA/mL) | |||
Median | 4 173 ± 8 988 | 26 314 ± 37 189 | .03 |
Range | (50-29 000) | (50-117 963) |